Everand Logo

Welcome to Everand!

  • STAT

    Sexual harassment allegations against Sam Isaly ripple through finance world

    A high-value client of Sam Isaly's firm, OrbiMed, is reviewing its relationship with the fund in the wake of sexual harassment allegations first published in STAT.
    by Damian Garde Dec 07, 2017 3 minutes

    As sexual harassment allegations against hedge fund titan Sam Isaly echo around Wall Street, one of his firm’s multibillion-dollar clients is reviewing its relationship with the fund, and Isaly has been removed from the agenda of an upcoming investor conference.

    Isaly, the 72-year-old founder and managing partner of OrbiMed Advisors, for years sexually harassed and demeaned female employees, six former OrbiMed employees have told STAT. Isaly has denied the allegations.

    Eaton Vance, an investment firm with more than $400 billion on Tuesday evening. The firm pays OrbiMed for investment advice.

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
    An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

    Related Books & Audiobooks